Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$828M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$788M |
| 3 |
Qualcomm
QCOM
|
+$771M |
| 4 |
Apple
AAPL
|
+$719M |
| 5 |
Baxter International
BAX
|
+$571M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.57B |
| 2 |
Wells Fargo
WFC
|
+$967M |
| 3 |
KKR & Co
KKR
|
+$455M |
| 4 |
Booking.com
BKNG
|
+$401M |
| 5 |
GGP
GGP Inc.
GGP
|
+$384M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.16% |
| 2 | Healthcare | 9.53% |
| 3 | Financials | 9.25% |
| 4 | Consumer Discretionary | 7.98% |
| 5 | Communication Services | 7.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
State Street SPDR S&P Emerging Markets Small Cap ETF
EWX
$693M
| $13.6M | ﹤0.01% |
303,809
-78,945
| -21% | -$3.68M |
|
2077
Sensata Technologies
ST
$6.79B
| $13.6M | ﹤0.01% |
274,591
-33,271
| -11% | -$1.74M |
|
2078
LiveRamp
RAMP
$2.3B
| $13.6M | ﹤0.01% |
275,286
-1,996,129
| -88% | -$88.4M |
|
|
CLLS
2079
Cellectis
CLLS
$285M
| $13.6M | ﹤0.01% |
481,450
+96,847
| +25% | +$2.78M |
|
|
RDUS
2080
DELISTED
Radius Health, Inc.
RDUS
| $13.6M | ﹤0.01% |
762,621
+282,969
| +59% | +$6.4M |
|
|
BSCP
2081
DELISTED
Invesco BulletShares 2025 Corporate Bond ETF
BSCP
| $13.6M | ﹤0.01% |
685,516
+41,605
| +6% | +$827K |
|
2082
Helix Energy Solutions
HLX
$1.41B
| $13.6M | ﹤0.01% |
1,372,960
+645,018
| +89% | +$5.88M |
|
|
B
2083
DELISTED
Barnes Group Inc.
B
| $13.6M | ﹤0.01% |
190,892
-26,838
| -12% | -$1.78M |
|
2084
Pacira BioSciences
PCRX
$997M
| $13.6M | ﹤0.01% |
275,769
+166,933
| +153% | +$7.22M |
|
2085
Cohen & Steers Closed End Opportunity Fund
FOF
$380M
| $13.6M | ﹤0.01% |
1,047,320
-47
| -0% | -$618 |
|
2086
Invesco Dorsey Wright Consumer Staples Momentum ETF
PSL
$85.5M
| $13.5M | ﹤0.01% |
188,786
+93,741
| +99% | +$6.75M |
|
2087
Fidelity MSCI Information Technology Index ETF
FTEC
$21.3B
| $13.5M | ﹤0.01% |
224,451
-19,294
| -8% | -$1.13M |
|
|
TAST
2088
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $13.5M | ﹤0.01% |
923,436
+729,322
| +376% | +$11.1M |
|
2089
Invesco S&P 500 BuyWrite ETF
PBP
$362M
| $13.5M | ﹤0.01% |
594,155
+54,912
| +10% | +$1.23M |
|
2090
iShares Global Comm Services ETF
IXP
$572M
| $13.5M | ﹤0.01% |
232,564
+33,837
| +17% | +$1.9M |
|
|
SAGE
2091
DELISTED
Sage Therapeutics
SAGE
| $13.4M | ﹤0.01% |
95,165
-25,704
| -21% | -$3.97M |
|
2092
First Trust NASDAQ 100 ex-Technology Sector Index Fund
QQXT
$159M
| $13.4M | ﹤0.01% |
253,251
-6,506
| -3% | -$339K |
|
2093
Baytex Energy
BTE
$2.92B
| $13.4M | ﹤0.01% |
4,616,825
+1,504,301
| +48% | +$4.61M |
|
2094
NovoCure
NVCR
$1.91B
| $13.4M | ﹤0.01% |
256,408
-7,098
| -3% | -$283K |
|
2095
Wabtec
WAB
$49.3B
| $13.4M | ﹤0.01% |
127,787
-2,864
| -2% | -$309K |
|
|
VVC
2096
DELISTED
Vectren Corporation
VVC
| $13.4M | ﹤0.01% |
186,970
-14,825
| -7% | -$1.06M |
|
|
FPL
2097
DELISTED
FIRST TRUST NEW OPPORTUNITIES MLP & ENERGY FUND
FPL
| $13.3M | ﹤0.01% |
1,389,176
-632,592
| -31% | -$6.52M |
|
2098
FTI Consulting
FCN
$4.18B
| $13.3M | ﹤0.01% |
182,318
-46,143
| -20% | -$3.4M |
|
2099
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.72B
| $13.3M | ﹤0.01% |
295,164
-20,499
| -6% | -$918K |
|
2100
iShares MSCI Sweden ETF
EWD
$595M
| $13.3M | ﹤0.01% |
405,181
+9,892
| +3% | +$314K |
|
Similar funds
Morgan Stanley's Q3 2018 Portfolio in Review
As of Q3 2018, Morgan Stanley held 7,051 positions worth $400B, up 7.9% from $370B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Morgan Stanley's Q3 2018 filing shows 207 new, 2,867 increased, 3,206 reduced and 165 closed positions. Its largest new stake was Elanco Animal Health: 9,012,591 shares worth $314M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.57B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q3 2018 buy was Elanco Animal Health: 9,012,591 shares worth $314M.
- Morgan Stanley added most to Intuitive Surgical in Q3 2018, an estimated $828M increase.
- Morgan Stanley's biggest Q3 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.57B.
- Morgan Stanley fully exited GGP Inc. in Q3 2018, selling an estimated $384M.
- Morgan Stanley's ten largest holdings make up 15% of its $400B portfolio in Q3 2018.
- Morgan Stanley opened 207 new positions and closed 165 in Q3 2018.
- Morgan Stanley's portfolio value rose 7.9% quarter-over-quarter to $400B.
Based on Morgan Stanley's 13F filing for Q3 2018, filed 14 Nov 2018.